Science Market Update

New Clinical Research Center Opens at Rutgers

Posted by Rebecca Inch-Partridge on Mon, Nov 20, 2017

The University of Rutgers recently opened the Adult Clinical Research Center on its New Brunswick campus. The Adult Clinical Research Center (CRC) is part of the Robert Wood Johnson University school of Medicine. The center outgrew its previous location on the third floor of the Robert Wood Johnson University Hospital and now occupies the 8th floor of the new East Tower medical building adjacent to the Hospital. This 11,646 square foot facility will make it possible for the CRC to double the number of studies they conduct over the next three years. Currently, there are 36 active and 20 pending clinical trials.

Read More

Tags: biomedical sciences, Bioresearch funding, Rutgers University, laboratory equipment suppliers, new medical buildings, lab products, Rutgers, New research center, BioResearch Product Faire, Biotechnology trade show

Jefferson U: Donations & NIH Funding Yields New Approaches to Treating Cancer

Posted by Rebecca Inch-Partridge on Tue, Nov 14, 2017

Each year, The Sidney Kimmel Cancer Center (SKCC) at Jefferson University Hospital receives approximately $72 million in grants for cancer research from organizations such as Susan Komen for the Cure. This year the SKCC received a $3 million donation from Esperanza and David Neu in order to establish the Neu Center for Supportive Medicine and Cancer Survivorship. The purpose of the Neu Center is to serve as a comprehensive resource for psycho-social care and research.

Read More

Tags: Pennsylvania, Northeast, Thomas Jefferson University, cancer research, NIH funded Research Projects, Philadelphia, PA, NIH funding, Cancer Center, ThomJeff, cancer research funding, BioResearch Product Faire, NIH awards 2017, 2017 research funding

Research News: U of Minnesota Grows Blood Vessels in Lab

Posted by Rebecca Inch-Partridge on Mon, Nov 13, 2017

Researchers at the University of Minnesota, Twin Cities have created a new lab-grown blood vessel replacement that is composed completely of biological materials, yet contains no living cells at implantation. It is the first-of-its-kind nonsynthetic, decellularized graft that becomes repopulated with the recipient’s own cells after implanted. This discovery could help tens of thousands of kidney dialysis patients each year. It could also be adapted for use as coronary and peripheral bypass blood vessels and tubular heart valves in the future.

Read More

Tags: sell lab equipment, University of Minnesota Twin Cities, Biomedical Engineering, lab suppliers, UMinn, Lab Product Sales, research news, Kidney Dialysis, BioResearch Product Faire, uminn research, NIH awards 2017

Harvard/Longwood Medical Area Institutes and Event

Posted by BCI Staff on Fri, Nov 10, 2017

Harvard Medical School, with facilities in the Longwood are aof Boston, is the third oldest medical school in the United States, founded in 1782, and is home to more than 700 students in the M.D. program, more than 140 in the D.M.D program, 556 in the Ph.D. program, and 155 in the M.D.‑Ph.D. program. Harvard Medical School is also affiliated with several teaching hospitals: the Beth Israel Deaconess Medical Center, the Brigham and Women’s Hospital and the Massachusetts General Hospital.

The Longwood Medical Area is known as one of the most prestigious educational, medical and research areas in the United States. Located along Longwood Avenue in Boston, Massachusetts, Longwood Medical Area (LMA) is made up of teaching hospitals, medical facilities, and non-medical facilities; as well as some top educational institutes, such as Harvard Medical School. 

Read More

Tags: 2014, Harvard University, 2013, Northeast, Longwood Medical Center, Boston, BioResearch Product Faire Event, Research, MA, Harvard, NIH funding

University of Georgia Receives $1.5 in Research Funding to Develop Brain Glue

Posted by Rebecca Inch-Partridge on Tue, Nov 07, 2017

According to the Centers for Disease Control and Prevention 153 people in the U.S. die from injuries that include a traumatic brain injury (TBI) every day. Currently, there are no effective treatments for moderate-to-severe TBIs. So those who do survive their injuries often live the rest of their lives with impaired thinking, memory, or movement. TBIs can also lead to personality and emotional changes. However, research being conducted at the University of Georgia, Athens (UGA) might lead to a treatment that could significantly improve the prognosis of those with brain injuries. This promising research into a glue-like substance for the brain recently won a $1.5 NIH grant award.

Read More

Tags: biomedical research, University of Georgia Athens, University of Georgia, NIH funded Research Projects, UGA, laboratory equipment suppliers, lab suppliers, BioResearch Product Faire, Laboratory product sales, Biotechnology trade show, NIH awards 2017, 2017 research funding, Brain Repair

UC Davis Researchers Receive $1.5M to Study Immune Cells for Tumor Treatment

Posted by Laura Braden on Mon, Nov 06, 2017

White blood cells help the immune system protect the body from infections and diseases. Along with attacking infections, white blood cells also have the ability to bring other cells together to help in the fight. With these known abilities of white blood cells, life science researchers have been researching ways to amplify the abilities of these cells to target specific illnesses, such as tumors. 

Read More

Tags: CA, University of California Davis Medical Center, University of California Davis, Cancer Treatment, Immune System, UCDMC, Sacramento, NIH funding, 2018

UMass Researcher Granted $2.3M to Study Tuberculosis

Posted by Laura Braden on Fri, Nov 03, 2017

Tuberculosis (TB) is an infectious disease that affects nearly 1/3 of the world's population. Although eradication efforts have been undertaken, none have been successful and TB is still a leading cause around the world. Even though there are treatment methods for this infection, they are not always successful at killing the bacteria that cause TB. This provides life science researchers with more questions and research topics, to better understand the infection and bacteria and what causes treatments to work occasionally, but not always

Read More

Tags: tuberculosis, University of Massachusetts Amherst, new research funding, MA, NIH funding, Amherst, UMASS, 2018, TB Research

Biomedical News: Charlie’s Law Opens Opportunities for Stem Cell Treatments in Texas

Posted by Rebecca Inch-Partridge on Thu, Nov 02, 2017

In June, the Texas legislature unanimously passed Charlie’s Law which allows patients with chronic and terminal diseases access to experimental stem cell interventions. The law, named after the late Texas State representative Charlie Howard, is the first of its kind in the U.S.

Read More

Tags: Stem cell research, Human Stem Cell, Texas Medical Center, Biomedical Reearch, TAMU, tmc, Biotechnology Vendor Fair, Texas A&M Research, Texas A&M Life Science Funding, biotech vendor show, Texas A&M, Research equipment, laboratory suppliers, BioResearch Product Faire, pollution

Scientific Sales at Washington University, St. Louis

Posted by Greg Paul on Wed, Nov 01, 2017

The Biotechnology Calendar, Inc. BioResearch Product Faire™ will be returning to Washington University, St. Louis for its 19th Annual event.  WashU's Life Science R&D Expenditures and NIH funding has been totaling about $1 Billion the past few years proving the University's dedication to being at the forefront of life science research and providing a prime opportunity for boosting scientific sales.

Read More

Tags: Washington University St. Louis, Washington University, WashU, MO, St Louis, 2018

Rockefeller U: NIH Research Funding May Lead to “Universal” Flu Vaccine

Posted by Rebecca Inch-Partridge on Wed, Nov 01, 2017

Most people don’t think of the flu as being life threatening. However, 36,000 American’s die because of the flu virus each year. Now, with the help of millions in NIH research funding, scientists at Rockefeller University have devised a strategy for improving existing flu vaccines. The new vaccines will better protect people against these ever-mutating viruses. And this new strategy might eliminate the need for annual flu shots, while at the same time saving thousands of lives. 

Read More

Tags: Rockefeller University, influenza research, RockU, Research Funding, Life Sciences, life science researchers, laboratory equipment suppliers, Lab Product Sales, Biomedical Research Funding, BioResearch Product Faire, Biotechnology trade show, biotech services, nih research funding

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News